| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Current Ratio | 1.32 | 1.47 | 1.83 | 1.89 | 1.77 |
| Fixed Assets | 5.51 | 5.17 | 5.23 | 5.38 | 2.84 |
| Inventory | 7.62 | 7.16 | 6.77 | 6.21 | 5.80 |
| Debtors | 14.47 | 16.44 | 16.18 | 15.29 | 18.52 |
| Interest Cover Ratio | 954.01 | 502.66 | 462.57 | 383.39 | 178.31 |
| PBIDTM (%) | 35.36 | 28.60 | 28.08 | 25.83 | 24.24 |
| PBITM (%) | 33.56 | 26.55 | 26.03 | 23.71 | 21.55 |
| PBDTM (%) | 35.32 | 28.55 | 28.02 | 25.77 | 24.12 |
| CPM (%) | 26.48 | 21.16 | 20.94 | 54.31 | 18.97 |
| APATM (%) | 24.68 | 19.11 | 18.90 | 52.19 | 16.28 |
| ROCE (%) | 58.72 | 44.44 | 33.60 | 32.11 | 32.10 |
| RONW (%) | 49.23 | 36.83 | 27.43 | 80.45 | 28.49 |